Work

Choice of starting dose for molecular targeted agents (MTA) evaluated in phase I cancer clinical trials (P1T)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.3586

Authors: L. Vidal-Boixader, C. Le Tourneau, L. L. Siu

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591013418

Cites:

Cited by:

Related to: 10